[Asia Economy Reporter Oh Hyung-gil] THE E&M announced on the 9th that it will acquire 600,000 shares of its manufacturing subsidiary, Luka AI Cell, which produces organic chemical substances, biological preparations, pharmaceuticals, and medical supplies, for 3 billion KRW.


After acquiring the shares, the ownership stake will be 100%. The scheduled date for the share acquisition is the 18th.



THE E&M stated, "This is for jointly establishing and operating a new corporation with Luka Health, a specialized company in artificial cell membranes, as a new investment project."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing